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Abstract
Background: Understanding how pathogens respond to antimicrobial peptides, and how this compares to currently
available antibiotics, is crucial for optimizing antimicrobial therapy. Staphylococcus aureus has several known resistance
mechanisms against human cationic antimicrobial peptides (CAMPs). Gene expression changes in S. aureus strain
Newman exposed to linear CAMPs were analyzed by DNA microarray. Three antimicrobial peptides were used in the
analysis, two are derived from frog, temporin L and dermaseptin K4-S4(1-16), and the ovispirin-1 is obtained from sheep.
Results: The peptides induced the VraSR cell-wall regulon and several other genes that are also up-regulated in cells
treated with vancomycin and other cell wall-active antibiotics. In addition to this similarity, three genes/operons were
particularly strongly induced by the peptides: vraDE, SA0205 and SAS016, encoding an ABC transporter, a putative
membrane-bound lysostaphin-like peptidase and a small functionally unknown protein, respectively. Ovispirin-1 and
dermaseptin K4-S4(1-16), which disrupt lipid bilayers by the carpet mechanism, appeared to be strong inducers of the
vraDE operon. We show that high level induction by ovispirin-1 is dependent on the amide modification of the peptide
C-terminus. This suggests that the amide group has a crucial role in the activation of the Aps (GraRS) sensory system,
the regulator of vraDE. In contrast, temporin L, which disrupts lipid bilayers by forming pores, revealed a weaker inducer
of vraDE despite the C-terminal amide modification. Sensitivity testing with CAMPs and other antimicrobials suggested
that VraDE is a transporter dedicated to resist bacitracin. We also showed that SA0205 belongs to the VraSR regulon.
Furthermore, VraSR was shown to be important for resistance against a wide range of cell wall-active antibiotics and
other antimicrobial agents including the amide-modified ovispirin-1, bacitracin, teicoplanin, cefotaxime and 10 other β-
lactam antibiotics, chlorpromazine, thioridazine and EGTA.
Conclusion: Defense against different CAMPs involves not only general signaling pathways but also CAMP-specific ones.
These results suggest that CAMPs or a mixture of CAMPs could constitute a potential additive to standard antibiotic
treatment.
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Background
The ubiquitous presence of cationic antimicrobial pep-
tides (CAMPs) in virtually all types of cells and organisms
ranging from bacterial cells to humans suggests that
CAMPs have important conserved roles as defense weap-
ons. CAMPs contribute to the host defense of microbial
invasion on epithelial surfaces by killing engulfed micro-
organisms in phagocytic cells or modulating inflamma-
tory responses in infections [1-3]. These ancient weapons
of host defense are typically amphipathic peptides with a
net positive charge at physiological pH and they share
well-defined  α-helical or β-sheet secondary structures.
CAMPs are able to integrate into cell membranes, form
membrane-spanning pores and thereby cause lethal cell
damage. The positive charge is important for the initial
binding of CAMPs to target membranes. There are differ-
ences in the way CAMPs interact with membranes and
accordingly three different models have been used to
define their mode of actions in model membrane systems
[4]. In the barrel-stave mechanism, peptides integrate into
the membrane and form membrane-spanning pores [5].
In the toroidal-pore mechanism, CAMPs form membrane-
spanning pores together with intercalated lipids [5]. And
in the carpet mechanism, peptides accumulate on the mem-
brane surface in a carpet-like manner and at a threshold
density so that they dissolve the membrane without form-
ing transmembrane channels [6]. However, membrane
damage is not the only mechanism whereby CAMPs cause
cell death. They may also affect functions of several other
cell components and act as metabolic inhibitors of cellu-
lar processes including biosynthesis of the cell wall,
nucleic-acids and proteins [1,3]. In these cases, the cell
death can be the result of multiple inhibitory effects.
Bacteria have evolved mechanisms to combat the harmful
effects of CAMPs [3]. On the other hand, the antimicro-
bial peptide repertoire in host cells may have co-evolved
with the evolution of microbial resistance mechanisms.
This is exemplified by the skin of the frog Rana temporaria
in which some temporins act in a synergistic manner to
overcome the resistance of Gram-negative bacteria
imposed by the lipopolysaccharide [7]. The high resist-
ance of Staphylococcus aureus to CAMPs produced by
human cells may contribute to epithelial colonization
and resistance to destruction by neutrophils. Several
mechanisms conferring increased resistance to CAMPs
have been identified. The modulation of the density of
negative charge in the cell wall by D-alanylation of tei-
choic acids (Dlt system) or on the outer surface of the cell
membrane by L-lysinylation of phosphatidylglycerol
(MprF) has been shown to contribute to CAMP resistance
in S. aureus [8,9] as well as in several other bacteria [10-
13]. In Gram-negative bacteria, LPS modifications modu-
late cell envelope charge and polymyxin susceptibility
[14-18]. Many bacteria species produce proteases which
cleave antimicrobial peptides, particularly linear ones [3].
S. aureus aureolysin and V8 as well as proteases secreted by
Bacillus anthracis are examples of proteases capable of
cleaving the human cathelicidin LL-37 [19,20]. The CAMP
resistance mechanisms also include CAMP-binding pro-
teins and CAMP efflux pumps [21-23].
Bacterial sensory systems are capable of recognizing cati-
onic antimicrobial peptides and to respond to their pres-
ence by up-regulation of general stress systems as well as
more specific CAMP resistance mechanisms. In Salmonella
typhimurium binding of CAMPs to the PhoQ two-compo-
nent sensor kinase activates the signal transduction cas-
cade from the sensor to the PhoQ response regulator,
resulting consequently in the induction of the PhoPQ-reg-
ulated promoters [24]. A complex stress response was
observed when Bacillus subtilis was exposed to CAMPs,
including activation of the SigW and SigM extracytoplas-
mic sigma factors and the YxdJK and LiaRS two-compo-
nent systems [25]. In this study, our purpose was to
characterize the stress response of S. aureus treated with
cationic antimicrobial peptides by using whole-genome
oligoarrays. The effects of three different α-helical CAMPs
on the transcriptome of the S. aureus Newman strain were
analyzed: temporin L, ovispirin-1 and dermaseptin K4-
S4(1-16). These peptides are synthesized as prepropro-
teins (precursors) and the mature microbicidal peptides
are formed after proteolytic cleavage of the pre- (signal
peptide) and pro-regions of the precursors [26,27].
Ovispirin-1 is a derivative of the cathelicidin SMAP-29
found in sheep [28]. The other two peptides, dermaseptin
K4-S4(1-16), which is a truncated derivative of the der-
maseptin S4, and temporin L, are both expressed in
amphibian skin [29,30]. Temporin L belongs to pore-
forming peptides (barrel-stave or toroidal pore mecha-
nism) [30,31] and ovispirin-1 and dermaseptin disrupt
lipid bilayers by the carpet mechanism [1]. We used these
well-characterized peptides of animal origin as models of
cationic antimicrobial peptides and expected that study-
ing their interactions with S. aureus would give informa-
tion that was more generally applicable also to human
CAMPs. We aimed to identify the CAMP stimulons and to
determine whether the differentially expressed genes play
a role in CAMP resistance. Furthermore, we were inter-
ested to find out whether there are strong peptide-specific
responses or a more general stress response triggered by
CAMPs exposition, to explore the mode of action of
CAMPs and to improve our understanding of the resist-
ance mechanisms against CAMPs.
Results
The VraSR cell wall regulon, vraDE, SA0205 and SAS016 
are strongly induced by cationic antimicrobial peptides
Exponentially growing S. aureus cells were treated with C-
terminally amidated temporin L (temporin L-NH2),BMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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ovispirin-1 (ovispirin-1-NH2) or dermaseptin K4-S4(1-
16) (dermaseptin K4-S4(1-16)-NH2) at sublethal concen-
trations (see Methods) which slightly inhibited growth
but did not stop it. Gene expression changes in the CAMP-
treated cells as compared to non-treated cells were ana-
lyzed by using whole-genome oligoarrays.
All three peptides upregulated a large number of genes
(63-247) and most of them were induced by more than
one peptide. Table 1 shows a set of the genes induced by
at least one of the peptides at least 3-fold and represents a
list of "marker" genes for the CAMP stimulon. The com-
plete list of the induced genes (higher than 2-fold induc-
Table 1: Genes induced by cationic antimicrobial peptides.
Gene ID Gene name* Induction with** Known regulation*** Protein/Similarity
TOD
SA0011 3.5 2.1 Similar to homoserine-o-acethyltransferase
SA0122 butA 3.2 2.1 VCM Acetoin reductase
SA0205 17.2 11.2 6.2 VCM Similar to lysostaphin precursor
SA0344 metE 4.5 2.3 VCM 5-methyltetrahydropteroyltriglutamate-homocysteine 
methyltransferase
SA0428 3.6 2.4 2.3 Hypothetical protein
SA0430 gltB 4.4 2.5 Glutamate synthase large subunit
SA0480 ctsR 4.2 4.2 Transcription repressor of class III stress genes homologue
SA0513 3.3 2.2 Conserved hypothetical protein
SA0591 3.0 3.3 2.1 VCM Hypothetical protein
SA0677 3.6 2.1 VCM Similar to choline transport ATP-binding protein
SA0781 3.1 2.1 Similar to 2-nitropropane dioxygenase
SA0817 5.0 2.7 Similar to NADH-dependent flavin oxidoreductase
SA0825 spsA 2.6 3.5 2.0 VraSR, VCM Type-1 signal peptidase
SA0835 clpB 3.9 4.1 VCM ClpB chaperone homologue
SA0845 oppB 4.3 2.0 VCM Oligopeptide transport system permease protein
SA0903 2.1 4.1 2.6 Conserved hypothetical protein 
SA1164 dhoM 5.2 2.8 VCM Homoserine dehydrogenase
SA1170 katA 4.3 2.6 Catalase
SA1216 3.8 2.4 Similar to oligoendopeptidase
SA1219 5.4 4.2 Similar to phosphate ABC transporter
SA1227 dapA 8.3 9.6 VCM Dihydrodipicolinate synthase
SA1254 3.1 3.5 VraSR, VCM Hypothetical protein
SA1476 4.2 5.3 3.3 VraSR, VCM Hypothetical protein
SA1517 citC 4.9 5.8 3.1 VCM Isocitrate dehydrogenase
SA1545 serA 4.6 2.5 VCM Similar to soluble hydrogenase 42 kD subunit
SA1549 htrA 2.9 3.0 2.0 VraSR, VCM Similar to serine proteinase Do, heat-shock protein HtrA
SA1599 3.2 2.4 Similar to transaldolase
SA1655 ecsA 3.0 3.0 ABC transporter EcsA homologue
SA1659 prsA 3.2 4.5 2.9 VraSR, VCM Peptidyl-prolyl cis/trans isomerase homologue
SA1701 vraS 3.9 5.3 2.5 VraSR, VCM Two-component sensor histidine kinase
SA1820 3.6 3.0 2.2 Similar to bacteriophage terminase small subunit
SA1836 groEL 3.8 4.3 2.2 GroEL protein
SA1862 leuA 13.5 3.3 2.1 2-isopropylmalate synthase
SA1990 3.4 2.6 2.2 Conserved hypothetical protein
SA2113 2.2 3.7 2.2 VraSR, VCM Hypothetical protein
SA2221 2.4 3.2 VraSR, VCM Hypothetical protein
SA2304 fbp 4.8 2.4 VCM Fructose-bisphosphatase
SA2324 4.9 2.6 2.0 Similar to thioredoxin
SA2343 4.3 4.3 2.7 VraSR, VCM Hypothetical protein
SA2397 3.5 2.3 VCM Similar to pyridoxal-phosphate dependent aminotransferase
SA2467 hisH 40.1 4.3 VCM Amidotransferase HisH
SA2492 vraD 8.2 32.4 17.2 VCM Similar to ABC transporter
SAS016 5.0 7.4 5.4 VCM Hypothetical protein
*: Only the most strongly upregulated genes, the marker genes of the CAMP stimulon, are shown in this table. The complete list of genes induced 
at least 2-fold by several CAMPs is shown in additional file 1. In the case of operons, only the first gene or the most strongly induced gene is shown;
**: T, temporin L-NH2; O, ovispirin-1-NH2; D, dermaseptin K4-S4(1-16)-NH2;
***: VCM, vancomycin inducible; VraSR, belongs to the VraSR regulon.BMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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tion) is shown in additional file 1. The microarray data
sets have been deposited in the GEO database (GPL7137
and GSE15800 for the complete microarray dataset) [32].
CAMPs induced the expression of the VraSR two-compo-
nent system and consequently almost the whole VraSR
regulon [33] was upregulated. In addition to the three
antimicrobial peptides of animal origin, we also recently
found that the human cathelicidin LL-37 induces the
VraSR regulon (data not shown). Among the most
strongly induced genes were vraDE, SA0205 and SAS016,
which encode an ABC-type transporter similar to a puta-
tive bacitracin efflux pump [34,35], a lysostaphin-like
cell-wall peptidase and a functionally-unknown peptide
of 55 amino acids, respectively. The antimicrobial peptide
treatment caused stress that induced general stress genes
such as the ctsR-clpC operon, groELS and dnaJK. The syn-
thesis of cell components involved in combating oxida-
tive stress, catalase (SA1170), a putative thioredoxin
(SA2324) and thioredoxin reductases (trxB), were also
among the induced genes. Furthermore, a feature of the
transcriptome was upregulation of several amino acid-
biosynthesis operons (dap, his, leu, and thr operons).
Genes involved in anaerobic energy metabolism or 
encoding virulence factors were down-regulated in 
CAMP-treated cells
There were also down-regulated genes in the transcrip-
tomes. Temporin L-NH2, ovispirin-1-NH2 and dermasep-
tin K4-S4(1-16)-NH2 decreased the expression of 219, 194
and 134 genes, respectively. Most of the genes were down-
regulated by more than one peptide (additional file 2).
Notably, all three peptides had a strong inhibitory effect
on the expression of genes involved in energy metabolism
under anaerobic conditions [36]. The genes encoding
enzymes for nitrate respiration (nar and nas operons) and
fermentation (pflP,  pflA,  ictE, and adh1) were strongly
repressed. Another striking phenomenon is that antimi-
crobial peptides caused down-regulation of several viru-
lence factors and their regulators (saeRS and agr). Among
the down-regulated virulence factor genes were hld, ssaA,
sbi, hlgA, ssl11 (set15), clfA, clfB and spa. The negative effect
was particularly strong on the expression of hld, ssl11, clfA
and clfB in cells treated with ovispirin-1-NH2.
qRT-PCR measurements of the differentially expressed 
genes
We used qRT-PCR to verify some of the most interesting
gene expression responses. The most strongly upregulated
genes of the transcriptome,vraD (SA2492), SA0205 and
SAS016 were subjected to qRT-PCR. The activity of the
VraSR regulon was determined with three genes, vraS
(SA1701), prsA (SA1659) and SA1477. The DNA microar-
ray data suggested that an operon encoding a putative
PstB-like phosphate uptake system (SA1217-SA1221) was
induced by ovispirin-1-NH2 and dermaseptin K4-S4(1-
16)-NH2 but not by temporin L-NH2 (Table 1 and addi-
tional file 1). This induction pattern suggests that the pep-
tide-induced expression from the promoter of the
SA1217-SA1221 operon may depend on the mode of
action of the antimicrobial peptides and we therefore
were interested in confirming the peptide-specific induc-
tion pattern by qRT-PCR. We determined the expression
level of SA1220. We also determined two further genes,
vraF (SA0616) and dltA (SA0793), which were induced
about 2-fold in the microarrays only by ovispirin-1-NH2.
The ortholog of vraF in B. subtilis is bceA, which encodes
the ATPase component of an ABC transporter. Since bceA
is strongly induced by bacitracin [34] and moderately by
linear cationic antimicrobial peptides [25], and since it is
also important for bacitracin resistance, we were inter-
ested in determining whether vraF  is induced in the
CAMP-treated cells of S. aureus. Furthermore, vraDE,
vraFG and the dlt operon are all regulated by the Aps (or
GraRS) sensory system [37]. The dlt operon encodes pro-
teins which modify wall teichoic acids and lipoteichoic
acids with D-alanine and thereby modulate the cell wall
charge [9]. The density of negative charge in the wall
affects the sensitivity of the bacteria to CAMPs.
The gene expression changes of the induced genes were
clearly higher in the qRT-PCR measurements than in the
DNA microarray, a previously described characteristic
[38,39], but overall consistency was found in the results.
The SAS016, vraD, SA0205, SA1477 and prsA genes exhib-
ited the strongest gene induction responses; over 100-fold
induction of SAS016 and vraD was observed with ovispi-
rin-1-NH2 (Figure 1). Most of the genes responded more
strongly to ovispirin-1-NH2 than temporin-L-NH2. This
was particularly clear in the induction of vraD  and
SA1220, but also vraF, dltA, prsA, SAS016 and SA1477
responded in this manner. SA0205 was the only gene
which was expressed at higher levels in temporin-L-NH2-
treated cells as compared to ovispirin-1-NH2-treated cells.
The gene expression responses to dermaseptin K4-S4(1-
16)-NH2 were in most cases similar to those of ovispirin-
1-NH2.
The negative effect of CAMPs on the expression of ssaA, sbi
and SA0423 was verified by qRT-PCR. Consistently with
the microarray results, these genes were down-regulated
in cells treated with the peptides (Figure 1). However, the
decrease in expression was clearly lower in the qRT-PCR
measurements.
The amide at the C-terminus of ovispirin-1 is crucial for the 
high level induction of vraDE
The three peptides used in the DNA microarray analysis
were modified with C-terminal amide groups. We studied
whether the amide affects gene induction by comparingBMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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the induction levels of four key genes in cells treated with
amide-modified or non-modified ovispirin-1 or amide-
modified temporin L. The determined genes were groEL, a
general stress gene, prsA, the activity of which reflects the
activity of the VraSR two-component system and the
severity of the stress in the cell wall [33], and SA0205 and
vraD, which were strongly induced by CAMPs. We also
determined how other types of antimicrobial agents
induce these genes. The antimicrobial agents were vanco-
mycin and teicoplanin, which inhibit cell wall biosynthe-
sis by interacting with the lipid II peptidoglycan precursor
[40], bacitracin, an antimicrobial agent which interferes
with the dephosphorylation of the peptidoglycan precur-
sor [41], and daptomycin, a lipopeptide antibiotic with a
specific mode of action on the cell membrane [42]. Fur-
thermore, a pentaglycin peptide, A(D-Glu)K(D-
Ala)GGGGGA(D-Glu)K(D-Ala), which mimics the pep-
tide cross-link of S. aureus peptidoglycan, was tested to see
whether a native cell wall peptide induces the expression
of the four genes. This peptide was not antimicrobial at
the concentration used, 20 μg/ml.
The results revealed that the C-terminal amide strongly
influenced the induction of vraD by ovispirin-1. In the
absence of the amide, vraD  was only induced 3.7-fold
(Table 2). In contrast, when ovispirin-1 was modified
with the amide, vraD was induced 136-fold. The MIC val-
ues of both of the ovispirin-1 peptides for the S. aureus
Newman strain were 20 μg/ml (Table 3), indicating that a
difference in the stability of the peptides does not explain
the large difference (about 35-fold) in the induction lev-
els. The amide-modified peptide was also a better inducer
of SA0205, prsA and groEL, but the difference was much
smaller, only 2-4-fold. The induction pattern of the cell
wall antibiotics vancomycin and teicoplanin was similar
to that of ovispirin-1 without the C-terminal amide: the
induction levels of SA0205 and prsA were clearly higher
than those of vraD and groEL. The vraD expression was
also strongly induced by bacitracin, almost 500-fold,
Induction or repression of genes in cells treated with cationic antimicrobial peptides as determined by qRT-PCR Figure 1
Induction or repression of genes in cells treated with cationic antimicrobial peptides as determined by qRT-
PCR. The measurements of a set of differentially expressed genes were performed after 10 min treatments. The standard 
deviations of SAS016 are 19 (temporin L-NH2) and 53 (ovispirin-1-NH2). The standard deviation of vraD (ovispirin-1-NH2) is 6.
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whereas the induction levels of SA0205 and prsA were
much lower, 30-50-fold. Thus the induction pattern was
similar to the amide-modified ovispirin-1. In contrast,
temporin L-NH2, despite the C-terminal amide and lower
MIC than ovispirin-1-NH2, was a poor inducer of vraD
(Table 2, Figure 1) and resembled in this respect the non-
modified ovispirin-1 and the cell wall antibiotics. The
pentaglycine peptide did not induce any of the four genes.
VraDE is an ABC transporter system dedicated to resist 
bacitracin, whereas VraSR two-component system affects 
the resistance against a wider spectrum of antimicrobial 
agents
Our experiments showed that the VraDE ABC transporter
and the VraSR two-component system are two CAMP-
inducible systems which could be important for bacterial
cells in resisting the harmful effects of CAMPs and possi-
bly other antimicrobial agents. In order to study this, we
constructed vraDE and vraSR null mutants and cultivated
the mutants and the parental S. aureus Newman strain in
Mueller-Hinton broth in the presence of various concen-
trations of the antimicrobials (two-fold serial dilutions)
and determined their MIC values (Table 3). The CAMPs
used in the susceptibility tests were, ovispirin-1-NH2,
ovispirin-1, temporin L-NH2, two lantibiotics nisin and
Pep5, human cathelicidin LL-37, and hBD3 defensin (the
latter three are not shown in Table 3). In addition, we
determined MICs for vancomycin, teicoplanin, bacitracin
and daptomycin.
The mutations were verified by PCR (see methods), but
also the expression of the vraD, SA0205, prsA and groEL
genes in the vraDE and vraSR null mutants exposed to
vancomycin was determined by qRT-PCR. The ΔvraDE
mutant did not express vraD mRNA, consistent with the
mutation (Table 4). The SA0205, prsA and groEL genes
were expressed at about the same level as in the wild-type,
3-60-fold induction (Tables 4). In the ΔvraSR  mutant,
SA0205 and prsA were expressed at a low level (3-fold
induction) consistent with the VraSR defect and suggest-
ing that not only prsA  but also SA0205 belong to the
VraSR regulon. Their induction at a low level in the
absence of VraSR may indicate that the expression is also
controlled by another sensory system.
The ΔvraDE mutant was clearly more sensitive than the
wild-type strains to bacitracin (about 10-fold difference in
MIC), but no other differences were observed in the anti-
microbial sensitivities. This strongly suggests that VraDE is
a bacitracin-specific detoxification pump. More differ-
ences were observed with the ΔvraSR mutant. It exhibited
increased sensitivity to teicoplanin (4-fold difference),
bacitracin (4-fold difference) and ovispirin-1-NH2 (2-fold
difference). The ΔvraSR mutation did not affect the sensi-
tivity to ovispirin-1, nisin, daptomycin, Pep5, LL-37 or
hBD3. The same mutations in another S. aureus strain
(RN4220) caused similar antimicrobial sensitivity differ-
ences, indicating that they are not strain specific (addi-
tional file 3).
In order to characterize further the phenotypes of the
vraDE and vraSR null mutants, we subjected them to phe-
notype microarray (PM) analysis (Biolog). The analysis
was performed with the PM11-20 sensitivity plates, which
Table 2: Induction of vraD, SA0205, prsA and groEL in S. aureus cells treated with peptides or cell wall-active antibiotics.
Antimicrobial agent and concentration** Fold induction*
Gene
vraD SA0205 prsA groEL
Ovispirin-1
100 μg/ml
3.7 (0.5) 5.1 (1.0) 7.2 (1.6) 2.5 (0.5)
Ovispirin-1-NH2
100 μg/ml
136.7 (8.7) 20.0 (0.7) 30.7 (1.7) 3.8 (0.4)
Temporin-L-NH2
2 μg/ml
4.6 (1.3) 15.1 (3.6) 6.4 (1.8) 4.0 (0.1)
Bacitracin
100 μg/ml
467.5 (15.3) 51.4 (0.8) 27.9 (4.5) 3.6 (0.1)
Vancomycin
5 μg/ml
6.6 (0.6) 25.5 (1.8) 32.7 (1.7) 1.9 (0.0)
Teicoplanin
2.5 μg/ml
2.5 (0.3) 35.7 (6.9) 32.1 (4.1) 3.0 (0.3)
Pentaglysin
20 μg/ml
1.0 (0.0) 1.3 (0.1) 1.3 (0.0) 1.1 (0.0)
*: The ratio of the expression level of the gene in S. aureus Newman treated for 10 minutes with the antimicrobial agent or peptide to that in 
untreated cells as determined by qRT-PCR. The induction ratios are means from three experiments. The standard deviations are in parenthesis;
**: The concentrations of the antimicrobials and peptides used in the analysis are 5 × MIC (see Table 3) with the exception of temporin-L-NH2, 
which was used at a subinhibitory concentration, and pentaglycine, which was not microbicidal at the 20 μg/ml concentration.BMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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allow the testing of 960 phenotypes and the identification
of increased or decreased sensitivities of the mutants as
compared to the wild-type reference strain to a wide vari-
ety of non-peptide antimicrobial agents. Phenotype
microarray analysis measures the reduction of tetrazolium
dye (see experimental section).
The ΔvraSR mutant was more sensitive than the wild-type
strain to a number of cell wall-active antibiotics including
several cephalosporins (additional files 4 and 5). This
result is consistent with a similar result of a previous study
on a vraSR null mutant of S. aureus N315 [33]. The PM
assay also suggested enhanced sensitivity to some other
antimicrobial compounds than antibiotics. We verified
the growth inhibitory effects of four of these antimicrobi-
als, cefotaxime, chlorpromazine, EGTA and sodium tung-
state, by cultivating the ΔvraSR mutant and the wild-type
S. aureus Newman strain in BHI medium on microtiter
plates containing 0.31 μg/ml, 0.8 mM, 31.25 μg/ml and
25 mM concentrations of these antimicrobials, respec-
tively, and measuring the optical densities of the cultures.
The ΔvraSR mutant was unable to grow in the presence of
these antimicrobials, while the wild-type strain grew sig-
nificantly (Figure 2). In addition to these major differ-
ences of sensitivity, several minor differences were also
observed, but we did not verify them in microtiter plate
cultures by optical density measurements. The vraSR null
mutant was resistant to macrolide antibiotics due to the
ery gene used in the mutant construction. The PM analysis
of the ΔvraDE mutant did not reveal any significant sensi-
tivity differences (not shown), suggesting again a dedi-
cated role for VraDE in bacitracin resistance.
Discussion
A prominent feature of the CAMP transcriptomes of S.
aureus Newman was the induction of the VraSR regulon.
The regulon consists of several genes involved in cell wall-
associated functions such as protein quality control, pro-
tein folding and modulation of cell wall biosynthesis
[33]. The induction pattern of the VraSR-regulated genes
was very similar to that observed with vancomycin-treated
cells in another transcription profiling study with another
S. aureus strain, N315 [33]. In addition to the effects on
membranes, several antimicrobial peptides such as nisin,
mersacidin and bacitracin inhibit cell wall biosynthesis
[41,43-45]. Whether the VraSR-inducing linear CAMPs
used in this study inhibit cell wall biosynthesis and cause
a cell wall defect cannot be judged from our data, but this
is the most likely explanation for the similar induction
patterns of the VraSR-regulated genes. A transcription pro-
filing study with a lipopeptide antibiotic daptomycin also
showed up-regulation of the the VraSR cell wall regulon
[46], which is probably caused by an inhibitory effect on
the cell wall biosynthesis [47], although the results fur-
thermore suggested that some of the up-regulated genes in
the daptomycin transcriptome were induced by its mem-
brane depolarization effect [46]. A similar dual effect has
also been shown with human β-defensin 3 [48].
In B. subtilis, the yxdLM operon, which encodes an ABC
transporter, is strongly induced by human cathelicidin LL-
37 in a manner dependent on the YxdJK two-component
system, but not at all by porcine protegrin PG-1 and a
model antimicrobial peptide poly-L-lysine [25]. This indi-
cates that antimicrobial peptides can be very specific in
activating stress sensors and the activation mechanism
Table 3: Antimicrobial sensitivity of the ΔvraDE and ΔvraSR mutants and their parental strain S. aureus Newman.
Antimicrobial agent MIC (μg ml-1)
ΔvraSR/S. aureus Newman ΔvraDE/S. aureus Newman S. aureus Newman
Ovispirin-1 20 20 20
Ovispirin-1-NH2 10 20 20
Temporin L-NH2 66 6
Nisin 6.25 6.25 6.25
Bacitracin 5 2.5 20
Daptomycin 2.5 2.5 2.5
Teicoplanin 0.125 0.5 0.5
Vancomycin 1 1 1
Table 4: Induction of vraD, SA0205, prsA and groEL in S. aureus 
ΔvraSR and ΔvraDE mutants treated with vancomycin.
Mutant Fold induction*
Gene
vraD SA0205 prsA groEL
ΔvraSR 7.9 (0.2) 2.5 (0.2) 3.2 (0.1) 2.1 (0.1)
ΔvraDE not expressed 60.4 (2.1) 36.0 (0.7) 3.1 (0.4)
wild type 6.6 (0.6) 25.5 (1.8) 32.7 (1.7) 1.9 (0.0)
*: The ratio of the expression level of the gene in the mutant or the 
wild-type strain treated for 10 minutes with 5 μg/ml of vancomycin to 
that in untreated cells as determined by qRT-PCR. The induction 
ratios are means from three experiments. Standard deviations are in 
parenthesis.BMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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Increased sensitivity of the ΔvraRS mutant to cefotaxime, EGTA, chlorpromazine and sodium tungstate Figure 2
Increased sensitivity of the ΔvraRS mutant to cefotaxime, EGTA, chlorpromazine and sodium tungstate. The 
ΔvraRS mutant and the wild-type S. aureus Newman strain were grown either in the presence or absence of the antimicrobial 
agents as indicated in 150 μl of BHI medium in wells of microtiter plates in a Bioscreen for 16 hours. The optical densities of 
the cultures were measured every 15 minutes. The data points show the densities measured at one-hour intervals.
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may even be dependent on the mode of action, charge or
structural properties of the peptides. In this study we
found that the vraDE ones were the most strongly induced
genes in cells treated with ovispirin-1-NH2 or dermaseptin
K4-S4(1-16)-NH2. We could demonstrate that the high
level of induction of vraDE  with ovispirin-1-NH2 was
dependent on the amide group at the C-terminus. The
antimicrobial effects of these two variants of ovispirin-1
on wild-type S. aureus Newman strain were not different.
The expression regulation of vraDE is under the control of
the Aps (GraRS) sensor system, which also controls the
expression of vraFG, encoding a putative peptide efflux
pump, dlt operon, encoding components responsible for
the D-alanylation of teichoic acids and modulation of the
net negative charge of the cell wall, and mprF, encoding
the MprF enzyme which catalyzes the lysinylation of
phosphatidylglycerol and modulates the charge of the
outer surface of the cell membrane [37]. It has been
shown that a nine-aminoacid loop of the ApsS sensor
exposed on the outer surface of the membrane interacts
with CAMPs when activating the sensor [37]. Our results
suggest that in linear peptides the C-terminal amide group
is an important element for the activation of the ApsS sen-
sor. In the study by Li and collaborators [37] the peptides
which naturally contain an amide group at the C-termi-
nus, indolicidin and melittin, were significantly better
inducers of the dltB gene than those that do not have the
amide such as magainin II and nisin. The vraDE genes
were also the most strongly induced genes in the stress
response to C-terminally amide-modified human catheli-
cidin LL-37 (our unpublished results). However, the low
level of induction of vraDE with temporin L-NH2 in this
study suggests that the C-terminal amide is not the only
element that is recognized by the ApsS sensor and needed
for the induction. Alternatively, the level of the induction
of the Aps regulon might rather depend on the absence of
the carboxyl group than on the presence of the amide.
Mersacidin, which is a lantibiotic, but unlike nisin, does
not have a free C-terminal carboxyl group due to an
intramolecular thioether-ethyleneamide bridge, is a very
strong inducer of vraDE [49] and might fit this model.
VraDE is a transporter system that is dedicated to resist
bacitracin, as evidenced in this study by the testing the
sensitivity of the vraDE null mutant(s) to 11 antimicrobial
peptides or antibiotics and numerous other antimicrobial
agents (PM analysis). The ΔvraDE mutant(s) was more
susceptible to bacitracin but not to any other antimicro-
bial tested. Consistently, VraDE is similar to the BceAB
bacitracin transport system of B. subtilis [34,35] and prob-
ably comprise together with VraFG an efflux pump system
for combating bacitracin [37]. A recent study suggested
that in B. subtilis bacitracin sensing and the expression of
the bceAB genes are dependent on active bacitracin trans-
port via BceAB and that the large periplasmic loop of the
BceA permease component of the transporter may be
involved in mediating the signal to the BceRS two-compo-
nent system [50]. We found that bacitracin is a strong
inducer of vraDE expression. Whether the sensing mecha-
nism of Aps is dependent on the transport function of
VraDE or VraFG, whether Aps senses linear CAMPs and
bacitracin in a similar manner and whether the amide
group of the side chain of glutamine in the cyclic baci-
tracin peptide [51] have a similar essential role in the acti-
vation, should be addressed in future studies. The C-
terminal amide being in a sequence contex that is appro-
priate for the interaction with the sensory loop of ApsS
most probably explains the differences in the induction
patterns of the vraDE, vraF and dltA genes observed in this
study. However, we can not rule out the possibility that
the carpet-mode of action mechanism influences the
induction, since the amide-modified carpet peptides
ovispirin-1-NH2 and dermaseptin K4-S4(1-16)-NH2 were
clearly stronger inducers of these genes than the amide-
modified toroidal pore-forming peptide temporin L-NH2.
In addition to vraDE, SA0205 was strongly induced by
CAMPs, but in this case the strongest inducer was tempo-
rin L-NH2. Our results indicated that SA0205, which
encodes a putative cell membrane-associated peptidase,
belongs to the VraSR regulon. The over 100-fold induced
(qRT-PCR) SAS016 encodes a small protein with
unknown function and mechanism of regulation. It was
also strongly induced by vancomycin [52], suggesting that
it responds to a cell wall defect. Furthermore, it was
detected at both transcript and protein levels in GISA
strains [53]. S. aureus cells try to adapt to the stress and
harmful effects of CAMPs by inducing or repressing sev-
eral gene systems. These responses include the induction
of the ctsR, dnaJ, dnaK, hrcA, groEL and groES general stress
genes and genes resisting oxidative stress (katA, trxB and
SA2324). Some of these targets showed similar inductions
in S. aureus during phagocytosis by neutrophils or when
surviving within epithelial and phagocytic cells [54,55].
Notably, several amino acid biosynthesis operons and
genes encoding enzymes of the citric acid cycle were also
induced and genes involved in anaerobic metabolism
were repressed, indicating that the cells were metaboli-
cally active and respiring aerobically. The down-regula-
tion of virulence gene expression is partly caused by the
repression of saeRS, but also the decreased expression of
the agr operon affects their low expression.
S. aureus is a human pathogen and it can be argued that
the CAMPs of animal origin may cause a different kind of
transcriptional response than CAMPs of the natural host.
A transcriptional analysis of responses of S. aureus
(SG511) to human β-defensin 3 (hBD3) showed that
vraDE,  vraSR  and SA0205 were also induced by this
human CAMP [48], as was the case with the animalBMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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CAMPs in this study. The most notable difference in the
transcriptomes is the very strong induction of the SA0192
gene, which encodes a protein similar to ABC transporter
ATP-binding proteins, in SG511 cells exposed to hBD3.
Since this gene is absent in the genome of the S. aureus
Newman strain, it is not among the induced genes of this
study. Sass and collaborators recently showed that a
knockout mutation of vraE increases the susceptibility of
S. aureus SG511 also to other antibiotics than bacitracin,
including antimicrobial peptides hBD3, LL-37, Pep5 and
nisin [48]. The defective GraRS/Aps sensory system of the
strain SG511 [56] may explain the inconsistency with the
result of this study.
The ΔvraSR mutant exhibited enhanced sensitivity to sev-
eral antimicrobial agents as compared to the wild-type
strains. They were more sensitive to the amide-modified
ovispirin-1 but not to the non-modified one. Ovispirin-1-
NH2 was a better activator of Aps and VraSR than ovispi-
rin-1 and this may explain the higher resistance of the
wild-type strain to the amide-modified peptide. The
ΔvraSR mutation also decreased the MIC values of baci-
tracin and teicoplanin. This effect is similar to what has
been observed with a ΔvraSR mutant of S. aureus N315
[33]. Our phenotype microarray analysis revealed
increased sensitivity of the S. aureus Newman  ΔvraSR
mutant to a wide range of β-lactam antibiotics. Further-
more, we showed that ΔvraSR increased susceptibility to
other types of antimicrobial agents such as EGTA and phe-
nothiazines. Since EGTA is a metal-chelator, it probably
harmfully affects bacterial cells and particularly severely
ΔvraSR mutant cell by binding to divalent metal cations in
the cell wall and consequently causing metal sequestra-
tion. The phenothiazines chlorpromazine and thiori-
dazine, which are or have been used in psychiatric
therapy, are potential lead compounds for the develop-
ment of new cell wall-active antibiotics. It has been shown
that the dosage of chlorpromazine used in psychiatry
results in intracellular concentrations of this drug that are
antimicrobial [57].
Conclusion
The current rapid increase in antibiotic resistance among
human pathogens coincides dangerously with a lack of
novel antibiotic discovery. A promising alternative is a
class of short peptides known as antimicrobial peptides,
or host defense peptides, which are found among all
classes of life but have yet to be widely exploited for phar-
maceutical purposes. In order to identify the inducible
resistance mechanism of Staphylococcus aureus against
antimicrobial peptides and other antimicrobial agents,
the bacterium was exposed to antimicrobial peptides and
gene expression changes were analyzed. The analysis
revealed similar gene induction patterns with cell wall-
active antibiotics but also some distinctly different ones.
The induction of the VraSR regulon suggests that antimi-
crobial peptides have an inhibitory effect on the cell wall
biosynthesis. This must be verified biochemically in
future studies. Parts of the signalling pathways are not spe-
cifically dedicated to CAMP defense but are regulated fol-
lowing the lifestyle of pathogenic bacteria which are
potentially exposed to a wide diversity of environmental
changes.
This study does not provide a definitive answer as to
whether the mode of action of CAMPs on lipid bylayers is
responsible for certain induction patterns, but this is a
potential alternative. For instance in the case of the induc-
tion of the SA1217-SA1221 operon, the carpet-forming
peptides ovispirin-1-NH2  or dermaseptin K4-S4(1-16)-
NH2 were strong inducers whereas the pore-forming pep-
tide temporin L-NH2 was unable to induce this operon.
Most importantly, it was found that modifying the car-
boxy-terminus of a linear peptide with an amide group
can modulate drastically its properties as an inducer of
resistance mechanisms. This result may allow the rational
design of antimicrobial agents that lack the properties to
induce resistance mechanisms. Inactivating the VraSR cell
wall stress management system increased susceptibility of
the bacterium to a wide range of cell wall-active antibiot-
ics but also susceptibility to several non-antibiotic antimi-
crobials was increased. Particularly interesting in the latter
group are the established antipsychotic drugs, chlorpro-
mazine and thioridazine, which are potential lead mole-
cules for developing novel antibiotics.
Methods
Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used are listed in Table
5. E. coli cells were grown in Luria-Bertani (LB) broth sup-
plemented with ampicillin (100 μg ml-1) and S. aureus
cells in BHI (Brain Heart Infusion) and TSB (Tryptone
Soya Broth) media supplemented with chloramphenicol
(10  μg ml-1) and/or erythromycin (2.5 μg ml-1) when
needed. To determine the subinhibitory concentrations of
temporin L-NH2  (FVQWFSKFLGRIL-NH2) ovispirin-1-
NH2(KNLRRIIRKIIHIIKKYG-NH2) and dermaseptin K4-
S4(1-16)-NH2 (ALWKTLLKKVLKAAAK-NH2), 150 μl of
BHI medium was inoculated with approximately 105 S.
aureus Newman cells in honeycomb 2 plate wells, pep-
tides were added in two-fold dilution series, and the cul-
tures were incubated with continuous and moderate
shaking at 37°C and culture densities were measured in a
Bioscreen C Microbiology reader (Growth Curves, Hel-
sinki, Finland). The peptide treatments for the gene
expression analyses were carried out in the exponential
growth phase (~OD560 = 0.6); CAMPs were added at the
final (sublethal) concentrations of 3 μM (temporin L-
NH2), 4 μM (ovispirin-1-NH2) and 3 μM (dermaseptin
K4-S4(1-16)-NH2) if not otherwise indicated. The addi-
tion of the peptides at these sublethal concentrations
slowed down the growth slightly. The peptides were pur-BMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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chased from EZbiolab (Carmel, IN, USA) and their purity
was 95%. The Minimal Inhibitory Concentration (MIC)
determinations were performed by cultivating S. aureus
Newman or RN4220 cells and their vraSR and/or vraDE
null mutation derivatives in 100% (temporin L-NH2,
ovispirin-1-NH2, ovispirin-1, nisin, vancomycin, baci-
tracin, teicoplanin, daptomycin and pentaglysine), 50%
(LL-37, nisin and Pep5) or 25% (hBD3) Mueller-Hinton
broth for 16-24 hours. Typically, an overnight grown cul-
ture was diluted 1/10000 and 1 ml of broth in a 15 ml
sterile Falcon tube was inoculated with 10 μl of the
diluted culture and cultivated at 37°C with shaking (220
rpm min-1). Each MIC determination was performed
twice with a two-fold dilution series of the antimicrobial
agents.
Isolation of total cellular RNA
The samples for RNA isolations were taken 10 minutes
after the addition of the antimicrobial peptides or other
antimicrobial agents at the cell density of OD600 = 0.6 or
Klett 50. The cells from 1.8-2 ml of the cultures (BHI
medium) were harvested by centrifugation. The superna-
tants were discarded and the bacterial pellets were frozen
in liquid nitrogen if the RNA isolation was not conducted
immediately. The control samples without peptides were
treated in a similar manner. The cell pellets were resus-
pended in 200 μl TE-buffer (10 mM Tris-HCl, 1 mM EDTA
pH 7.0) containing lysostaphin (125 μg ml-1) and incu-
bated at 37°C for 10 minutes. RNA was extracted by using
Roche's High Pure RNA Isolation Kit according to the
manufacturer's instructions.
Transcriptional analysis by oligo DNA microarray
The effects of the three different antimicrobial peptides on
gene expression of S. aureus Newman were studied by
using whole genome oligo-DNA microarrays. Bacteria
were grown in BHI medium to the early exponential phase
(OD600 = 0.6) and antimicrobial peptides were added at
the sublethal concentrations described above. Samples
were taken for RNA isolations after treating the cultures
with the peptides for 10 minutes. Control cultures with-
out peptide additions were treated similarly and in paral-
lel. Genes with at least 2-fold induction/reduction of
expression in the peptide-treated cells as compared to the
control cells (non-treated) were accepted as differentially
expressed genes.
The microarray was manufactured by in situ synthesis of
10'807, 60-mer oligonucleotide probes (Agilent, Palo
Alto, CA, USA), selected as previously described [38]. It
covers >98% of all ORFs annotated in strains N315 and
Mu50 [58], MW2 [59] COL [60], NCTC8325 (the
sequence, locus NC_007795, can be found at the National
Center for Biotechnology Information [61]), USA300
[62], MRSA252 and MSSA476 [63] including their respec-
tive plasmids. Extensive experimental validation of this
array has been described previously, using CGH (compar-
ative genomic hybridization), mapping of deletion, spe-
cific PCR and quantitative RT-PCR [38,64].
Total RNA was further purified with Qiagen RNeasy mini
kit and treated with DNAse following the manufacturer's
recommendations. The absence of remaining DNA traces
was evaluated by quantitative PCR (SDS 7700; Applied
Biosystems, Framing-ham, MA) with assays specific for
16s rRNA [53,65]. Samples of 8 μg total S. aureus RNA
were labelled by Cy-3 or Cy-5 dCTP using the SuperScript
II (Invitrogen, Basel, Switzerland) following the manufac-
turer's instructions. Labelled products were then purified
with QiaQuick columns (Qiagen). A mixture of control
(without peptide) and test conditions (with peptide) was
then diluted in 250 μl Agilent hybridization buffer, and
Table 5: Bacterial strains and plasmids.
Strain/Plasmid Description Reference/Origin
E. coli
5-alpha cloning strain New England Biolabs
S. aureus
Newman ATCC25904, methicillin susceptible [72]
RN4220 NCTC 8325-4-r, restriction negative strain [73]
COL methicillin resistant (MRSA) [60]
RH7657 Newman ΔvraSR::ery this study
RH7661 Newman ΔvraDE::ery this study
RH7788 RN4220 ΔvraDE::ery this study
RH7790 RN4220 ΔvraSR::ery this study
Plasmids
pGEM-3zf(+) cloning vector, ampr (E. coli) Promega
pKOR1 gene replacement vector, ampr (E. coli), chlr (S. aureus) [69]
pKTH3762 pGEM-3zf(+) containing the vraSR deletion cassette, ampr (E. coli) this study
pKTH3763 pKOR1 containing the vraSR deletion cassette, ampr (E. coli), chlr eryr (S. aureus) this study
pKTH3764 pGEM-3zf(+) containing the vraDE deletion cassette, ampr (E. coli) this study
pKTH3765 pKOR1 containing the vraDE deletion cassette, ampr (E. coli), chlr eryr (S. aureus) this studyBMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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hybridized at a temperature of 60°C for 17 hours in a ded-
icated hybridization oven (Robbins Scientific, Sunnyvale,
CA, USA). The slides were washed with Agilent proprie-
tary buffers, dried under a nitrogen flow, and scanned
(Agilent, Palo Alto, CA, USA) using 100% PMT (photom-
ultiplier tube) power for both wavelengths.
Fluorescence intensities were extracted using the Feature
extraction™ software (Agilent, version 8). Local back-
ground-subtracted signals were corrected for unequal dye
incorporation or unequal load of labelled product. The
algorithm consisted of a rank consistency filter and a
curve fit using the default LOWESS (locally weighted lin-
ear regression) method. Data consisting of three inde-
pendent biological experiments were analyzed using
GeneSpring 7.3 (Agilent) after per gene and per chip nor-
malization. The statistical significance of differentially
expressed genes was identified by variance analysis
(ANOVA) [53,66], performed using GeneSpring, includ-
ing the Benjamini and Hochberg false discovery rate cor-
rection (5%). Genes showing significant changes (P <
0.05) and at least a 2-fold induction/reduction of expres-
sion, in the peptide-treated cells as compared to the con-
trol cells (non-treated) were accepted as differentially
expressed.
Quantitative real-time RT-PCR
cDNA was synthesized with 1 μg of total cellular RNA by
using a High Capacity cDNA Archive Kit (Applied Biosys-
tems) with an additional step of DNase I (Roche) treat-
ment [67] The quantitative real-time PCR was performed
as previously described [25] by using specific primer pairs
and a SYBR Green PCR system kit (Applied Biosystems).
The primers (additional file 6) were purchased from TAG
Copenhagen. The amplification reactions and detection
of PCR products were performed with a 7500 real time
PCR system (Applied Biosystems). The cDNA values were
normalized with the value of gyrA.
Construction of the vraDE and vraSR null mutants
In order to construct null mutants of the vraDE and vraSR
operons, about 1 kb DNA fragments of both the upstream
and downstream regions of the target operons were PCR
amplified. The template DNA was S. aureus chromosome
either from the strain Newman (vraSR) or COL (vraDE).
The primers used in the PCR reactions are shown in addi-
tional file 6. The upstream fragments digested with PstI
and  SalI and the downstream fragments digested with
BamHI and EcoRI/SacI were ligated with a PCR-amplified
DNA fragment containing the erythromycin resistance
gene of pMUTIN4 [68]. The resulting vraDE and vraSR
inactivation cassettes were inserted into the pGEM3Zf(+)
plasmid vector between the PstI and EcoRI/SacI sites, fol-
lowed by transformation of competent E. coli 5-alpha
(NEB) cells with the ligated DNA. The inactivation cas-
settes were then PCR amplified by using the pGEM3Zf(+)
constructs as PCR templates and specific oligonucleotides,
containing the sequences of attB1 and attB2 sites, as PCR
primers. The amplified fragments were inserted into the
pKOR1 gene replacement plasmid in a recombination
reaction with Clonase (Invitrogen) as previously
described [69]. The resulting pKOR1-inactivation cassette
constructs were used to transform electrocompetent S.
aureus RN4220 cells by electroporation [70] and trans-
formants were selected by cultivating them on BHI agar
plates supplemented with chloramphenicol (10 μg ml-1)
and erythromycin (2.5 μg ml-1) at 30°C. The gene replace-
ment plasmids were isolated from the RN4220 transform-
ants and subsequently electroporated into S. aureus
Newman cells. The mutant construction was performed as
described [69]. Briefly, S. aureus Newman or RN4220 cells
harbouring the gene replacement plasmids were culti-
vated in TSB medium overnight at 43°C, a non-permis-
sive temperature for the replication of pKOR1 and its
derivative plasmids, to force the plasmids to integrate into
the chromosome by a Campbell-type recombination at a
flanking region of the target gene. The resulting merodip-
loid cells were cultivated on TSA plates containing 100 ng
ml-1  anhydrotetracyclin but not chloramphenicol to
induce pKOR1-encoded secY  antisense transcripts and
counter-select cells which via homologous recombination
between the gene duplicates had lost the pKOR1. The
presence of erythromycin (2.5 μg ml-1) on the plates
allowed the selection of the mutants. The mutants were
verified by PCR with appropriate primers (additional
file 6).
Phenotype microarray (PM) analysis of the vraDE and 
vraSR null mutants
The PM analysis was carried out by using the service of
Biolog (Hayward, CA, USA). We wanted to identify anti-
microbial agents and stress conditions which are more
harmful to the mutant cells than the wild-type S. aureus
Newman cells. Therefore, the analysis was performed only
with sensitivity panels 11-20, which allowed the testing of
960 stress conditions and 240 different antimicrobial
agents on ten 96-well plates. The method has been
described more thoroughly in a previous study [71].
Briefly, the growth of bacteria in a well of the PM panels
can be quantitated since growing, metabolically-active
bacteria reduce the tetrazolium indicator dye and blue
color is formed. Bacteria were grown in BHI medium for
24 hours in an OmniLog instrument. The color changes of
the redox dye in the cultures were compared (mutant ver-
sus wild type). The formation of the reduced tetrazolium
was recorded either as a green tracing (mutant) or a red
tracing (wild-type strain). The OmniLog PM bioinformat-
ics software was used to overlay the color-coded images of
the kinetics of the tetrazolium reduction and compare and
quantify them. Each strain was analyzed twice and con-BMC Genomics 2009, 10:429 http://www.biomedcentral.com/1471-2164/10/429
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sensus images were obtained showing the differences in
antimicrobial sensitivity that were detected in both PM
runs.
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